1
2
3

Information List

The special research and evaluation team of the provincial and municipal production reform joint meeting came to Beta Medicine for investigation and research.

2022-01-05

Beta Pharmaceuticals Selected as a Qualified Enterprise in Wuxi Enterprise Credit Management Training in 2021

2022-01-05

Beta Medicine Won Second Prize of 2021 Invention and Innovation Award

2022-01-05

Beta Pharmaceuticals through ISO9001 quality system certification

2022-01-05

Wuxi Beta Pharmaceutical Technology Co., Ltd. Science and Technology Association was formally established

2022-01-05

[Xi Bao] Beta Medicine Successfully Passs Intellectual Property Standard Certification

2021-11-30

[Xi Bao] Beta Medicine Successfully Passs Intellectual Property Standard Certification After more than half a year of preparation for the implementation of the standard, recently, Beta Pharmaceuticals successfully passed the certification of the implementation of intellectual property rights and obtained the certification certificate issued by China International Lianheng (Beijing) Certification Co., Ltd. "Implementation of the standard", that is, the implementation of the "Enterprise Intellectual Property Management Code" (GB/T 29490-2013). This specification is my country's first national standard for enterprise intellectual property management. It was formulated by the State Intellectual Property Office on March 1, 2013. The former General Administration of Quality Supervision, Inspection and Quarantine and the National Standardization Administration approved the promulgation and implementation. The smooth passing of the certification of intellectual property standards means that Beta Pharmaceuticals has achieved phased results in the establishment and implementation of the intellectual property management system, and the standardized implementation of the company's intellectual property rights has entered normalization, laying the foundation for the implementation of the intellectual property strategy. Standardized management will contribute to future development.

Beta Pharmaceuticals successfully passed the acceptance of the "Academician Workstation of Jiangsu Province" project.

2021-11-30

Beta Pharmaceuticals successfully passed the acceptance of the "Academician Workstation of Jiangsu Province" project. Recently, the Provincial Department of Science and Technology issued the "Notice on the Acceptance Results of Provincial Academician Workstations in 2021", and Wuxi Beta Pharmaceutical Technology Co., Ltd. successfully passed the acceptance of the "Jiangsu Academician Workstation" project. Wuxi Beta Pharmaceutical Technology Co., Ltd. was approved by the Provincial Department of Science and Technology and the Department of Education to build the "Jiangsu Province Academician Workstation" on October 31, 2019 ". This is the only government-licensed academician workstation created by Academician Zhou Yongmao, a senior expert in the field of nuclear reactors in China and a senior member of the new National Nuclear Safety Expert Committee. In the past three years, under the guidance of Academician Zhou, the research team of Beta Pharmaceutical has carried out a series of research and development of key core technologies and achieved remarkable results. At the previous acceptance meeting, Cai Dinglong, the chief technical officer of Beta Pharmaceuticals and the project leader of the academician workstation, made a project acceptance report on the "Jiangsu Province Academician Workstation. The project acceptance committee carefully reviewed the relevant materials, and after expert questions, enterprise defense and other procedures, the final acceptance committee believed that Wuxi Beta Pharmaceutical Technology Co., Ltd. relied on the construction of Academician Zhou Yongmao's workstation to complete the construction tasks and assessment indicators stipulated in the contract, and unanimously agreed to pass the acceptance. The academician workstation of Jiangsu Province aims to guide the innovation needs of enterprises, rely on enterprise R & D institutions, and use industry-university-research cooperation projects as a link to guide academicians and their innovation teams inside and outside the province to gather and serve enterprises, and to overcome the core key technologies of the industry. Promote the industrialization of scientific and technological achievements, cultivate a team of enterprise innovation talents, and provide strong support for enhancing the independent innovation ability and market competitiveness of enterprises.

Xu Dongqing, Chairman of the Jiangyin CPPCC, and his party investigated Beta Pharmaceuticals and inspected the cultivation of innovative enterprises.

2021-11-30

Xu Dongqing, Chairman of the Jiangyin CPPCC, and his party investigated Beta Pharmaceuticals and inspected the cultivation of innovative enterprises. On the afternoon of July 19, Chairman Xu Dongqing of Jiangyin CPPCC led all members of the CPPCC organs and some members of the CPPCC Economic, Science, Technology and Agricultural and Rural Committee to investigate Beta Medicine and inspect the cultivation of innovative enterprises, aiming to further focus on innovation-driven and help our city speed up the realization of higher-end industries and more surging innovation. Vice Mayor Gu Wenyu accompanied the investigation and inspection. In Beta Pharmaceuticals, Chairman Xu Dongqing and his entourage learned with great interest about the development status of China's nuclear technology application, the development of the carbon -14 isotope field, and the progress of Beta Pharmaceuticals industrialization. They visited the isotope labeling laboratory and encouraged Dr. Li Gang, chairman of Beta Pharmaceuticals, to speed up the industrialization process and make the enterprise bigger and stronger. At the work symposium in the afternoon, Chairman Xu Dongqing hoped in his speech that relevant departments-- It is necessary to improve the position, strengthen confidence, further recognize the extreme importance and urgency of the cultivation of innovative enterprises, resolutely put scientific and technological innovation in the most prominent position, and emancipate the mind and renew ideas as the forerunner to promote the "breaking the situation" of the work, and make more vigorous efforts to innovation. It is necessary to grasp the key points, find the right path, accelerate the pace of cultivating innovative enterprises, focus on the goal of building the first batch of innovative counties (cities) in the country with high standards, strengthen the targeting of policy support, improve the high-energy level of scientific and technological innovation carriers, and pay attention to talents The strong magnetic field of education, increase the precision of service guidance, and continuously improve the core competitiveness of the city. It is necessary to strengthen organizational guarantees, strengthen overall planning and coordination, optimize the environment for innovation and entrepreneurship, and comprehensively gather innovative enterprises to cultivate strong synergy. Chairman Xu Dongqing also asked the CPPCC system to give full play to its intelligence-intensive advantages. In particular, members of the economic and scientific and technological circles should strengthen their responsibilities, closely focus on the central work of the city, carry out in-depth consultation and discussion of politics, and actively provide suggestions and suggestions for Jiangyin's implementation. The strategy of "fighting between the South and the North and fighting between the East and the West" contributes wisdom and strength to being a pioneer in high-quality development, modernization drive, and regional integration development.

Wuxi Beta Pharmaceutical Technology Co., Ltd. Science and Technology Association was formally established

2021-11-29

无锡贝塔医药科技有限公司科学技术协会正式成立 11月16日下午，无锡贝塔医药科技有限公司召开科学技术协会成立大会，江阴市科协副主席杨红波、组宣部部长邱克玉，高新区科技局局长夏天华、副局长许磊及有关部门负责人和公司董事长李刚、总裁曹卫秋、CEO朱称古以及公司全体科技工作者参加了会议。 会上，贝塔医药科协筹备小组作了筹备工作汇报，江阴市科协组宣部部长邱克玉宣读了关于同意成立无锡贝塔医药科技有限公司科学技术协会的批复，与会代表审议并通过了贝塔医药科协章程和选举办法。大会选举产生了贝塔医药科协第一届委员会委员，并召开第一届委员会第一次会议选举产生了主席、副主席、秘书长人选，李刚董事长宣读有关人选。 市科协副主席杨红波对贝塔医药科协的成立表示祝贺，并为贝塔医药科协授牌。   会上，杨红波副主席对贝塔医药企业科协提出了三点期望：一要强化科技支撑，投身创新江阴建设。希望企业科协大力开展创新服务活动，组织广大科技工作者在本职岗位上创先争优、在科技攻关任务中勇挑重担，推动企业科技进步与创新发展，为江阴高质量发展提供源源不断的创新活力、创造动力。二要深化建家交友，提供优质精准服务。希望企业科协充分发挥优势，以对科创产业“时光不语、静待花开”的定力，以对人才团队“政策给力、服务贴心”的氛围，建好科技工作者之家，当好科技工作者之友，为科技工作者提供优质精准服务。三要发挥组织优势，构建高效科创生态。要加强对企业科协的日常管理和服务保障，为企业科协开展工作创造良好条件，支持企业科协开展各项活动，在打通科技成果转化“最后一公里”上发挥独特作用。 高新区科技局局长夏天华肯定了贝塔医药在科技创新方面做出的成绩及为高新区发展做出的贡献，他希望贝塔医药成立科协后：一要投身自主创新，在创新驱动发展中发挥作用。充分发挥企业在创新活动中的引导作用，有效整合创新力量；要充分发挥自身特长和优势，围绕企业发展积极建言献策，努力提出高质量的意见建议，多出好主意和“金点子”。二要壮大科技队伍，在创优人才成长环境中多出实招。把加强科技人才队伍建设作为强企之基、转型之要，在创新实践中发现人才、培养人才、凝聚人才、成就人才，让一切创新想法得到尊重、一切创新举措得到支持、一切创新才能得到发挥、一切创新成果得到肯定，在企业中切实形成人才辈出、人尽其才的生动局面。三要致力科普宣传，在提高员工科学素质中大显身手。以提高企业员工科学素质为己任，深入员工开展科普宣传教育活动，推广最新科研成果，努力争当科学知识的传播者、科学方法的实践者、科学思想的倡导者、科学精神的弘扬者，在企业中形成讲科学、爱科学、学科学、用科学的良好风尚。 新当选的贝塔医药科协主席朱称古在会上作了表态发言，表示将充分发挥企业科协的桥梁纽带作用，促进科技工作者之间的交流及人才培养，引导企业科技工作者积极创新争先，为江阴“产业更高端、创新更澎湃”做出新的更大贡献。新一届委员会将精诚团结、务实高效、与时俱进、开拓创新，争做勤于学习的模范、善于创新的模范、甘于奉献的模范，影响和带动公司广大科技工作者紧紧围绕公司打造碳-13（C13）领域国内龙头企业、碳-14（C14）领域国际龙头企业的目标战略，以及公司下达的年度生产经营、新项目建设、新品研发等各项具体目标任务，立足岗位，努力钻研，大胆创新，勤奋工作，自觉奉献，努力开创各条线工作的新局面，为早日实现公司的宏伟蓝图争做贡献，为江阴高质量发展做出我们科技工作者的贡献。 会后，贝塔医药科协第一届委员和与会领导合影留念。

Lu Jun, vice chairman of Wuxi Association for Science and Technology, and his party came to Beta Medicine for investigation and investigation.

2021-11-29

Lu Jun, vice chairman of Wuxi Association for Science and Technology, and his party came to Beta Medicine for investigation and investigation. On the morning of August 25, Lu Jun, vice chairman of Wuxi Association for Science and Technology, Yang Hongbo, vice chairman of Jiangyin Association for Science and Technology, and Xu Lei, deputy director of Jiangyin High-tech Zone Science and Technology Bureau, visited Jiangyin Yangzijiang Bioaccelerator Park to carry out on-site investigation of offshore bases and Haizhi bases. The first stop came to Beta Pharmaceuticals. Dr. Li Gang, representative of Wuxi Association for Science and Technology and chairman of Beta Pharmaceuticals, reported on the development of the company. Vice Chairman Lu Jun spoke highly of Beta Pharmaceuticals's focus on nuclear technology applications (isotopes) to build a carbon -14 industry chain, focusing on research and development, deep cultivation, filling the domestic gap, benefiting the country and the people, taking root downward in the first ten years, and starting to break through the development of these years. Science and technology associations at all levels should help enterprises build domestic and international technology exchange platforms to help enterprises develop better and faster. The leader of the Jiangyin Association for Science and Technology stated that Jiangyin organizes the selection of the "Top Ten Science and Technology Stars" every two years to commend outstanding scientific and technological workers and encourage enterprises to actively declare. At the same time, assist enterprises to hold domestic or international academic exchange meetings, so that scientific and technological talents can also access the most cutting-edge technical information in Jiangyin, and help enterprises retain talents.

< 12345 >